From: Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
 | Quartile | MetS/Total, n (%) | model 1 | model 2 | model 3 | model 4 |
---|---|---|---|---|---|---|
TSH | 1 | 388/3726 (10.4) | 1 | 1 | 1 | 1 |
2 | 428/3710 (11.5) | 1.122 (0.970–1.298) | 1.149 (0.989–1.334) | 1.192 (1.025–1.386) | 1.162 (0.984–1.372) | |
3 | 451/3729 (12.1) | 1.184 (1.025–1.367) | 1.165 (1.005–1.351) | 1.219 (1.049–1.417) | 1.046 (0.885–1.236) | |
4 | 493/3735 (13.2) | 1.308 (1.136–1.507) # | 1.212 (1.053–1.061) | 1.288 (1.110–1.494) | 1.167 (0.990–1.375) | |
FT4 | 1 | 523/3784 (13.8) | 1 | 1 | 1 | 1 |
2 | 417/3707 (11.2) | 0.790 (0.689–0.907) | 0.761 (0.660–0.876) # | 0.757 (0.656–0.874) # | 0.854 (0.728–1.002) | |
3 | 423/3624 (11.7) | 0.824 (0.718–0.945) | 0.762 (0.661–0.877) # | 0.758 (0.657–0.874) # | 0.900 (0.767–1.057) | |
4 | 397/3785 (10.5) | 0.731 (0.636–0.840) # | 0.651 (0.564–0.752) # | 0.620 (0.535–0.717) # | 0.819 (0.696–0.964) | |
FT3 | 1 | 317/3104 (10.2) | 1 | 1 | 1 | 1 |
2 | 482/4361 (11.1) | 1.095 (0.943–1.272) | 1.179 (1.011–1.375) | 1.154 (0.988–1.348) | 1.095 (0.923–1.299) | |
3 | 521/3897 (13.4) | 1.357 (1.170–1.574) # | 1.644 (1.410–1.916) # | 1.558 (1.334–1.819) # | 1.515 (1.276–1.798) # | |
4 | 439/3538 (12.4) | 1.245 (1.068–1.452) | 1.819 (1.550–2.134) # | 1.707 (1.451–2.008) # | 1.622 (1.354–1.942) # | |
FT3FT4 | 1 | 374/3724 (10.0) | 1 | 1 | 1 | 1 |
2 | 392/3718 (10.5) | 1.056 (0.909–1.226) | 1.227 (1.051–1.432) | 1.217 (1.041–1.423) | 1.241 (1.045–1.473) | |
3 | 438/3726 (11.8) | 1.193 (1.031–1.381) | 1.557 (1.337–1.813) # | 1.539 (1.319–1.795) # | 1.423 (1.201–1.687) # | |
4 | 556/3732 (14.9) | 1.568 (1.364–1.803) # | 2.372 (2.045–2.751) # | 2.329 (2.004–2.705) # | 1.798 (1.522–2.125) # |